Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT02497352

Effects of Flaxseed Supplementation in Metabolic Syndrome

Sponsor: National Nutrition and Food Technology Institute

Interventions flaxseed lifestyle modification

Updated 5 times since 2017 Last updated: Jul 13, 2015 Started: Feb 28, 2014 Primary completion: Aug 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02497352, this PHASE2/PHASE3 trial focuses on Metabolic Syndrome and remains completed. Sponsored by National Nutrition and Food Technology Institute, it has been updated 5 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Nutrition and Food Technology Institute

Data source: National Nutrition and Food Technology Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.